SPECIAL ARTICLES
1491 -- Clinical Pharmacy, Pharmaceutical Care, and the Quality of Drug Therapy
Charles D. Hepler, Ph.D.
1499 -- Clinical Pharmacy and Pharmaceutical Care
John A. Bosso, Pharm.D., FCCP
ORIGINAL RESEARCH ARTICLES
1501 -- Bioavailability and Lack of Toxicity of S-Adenosyl-L-Methionine (SAMe) in Humans
Jessica L. Gšren, Pharm.D., Andrew L. Stoll, M.D., Karen E. Damico, B.A., Ingrid A. Sarmiento, B.A., and Bruce M. Cohen, M.D., Ph.D.
1508 -- The Influence of St. John's Wort on the Pharmacokinetics and Protein Binding of Imatinib Mesylate
Patrick Smith, Pharm.D.
RESEARCH REPORTS
1515 -- Work-Related Outcomes After a Myocardial Infarction
Christopher R. McBurney, Pharm.D., Kim A. Eagle, M.D., Eva M. Kline-Rogers, M.S., R.N., Jeanna V. Cooper, M.S., Dean E. Smith, Ph.D., and Steven R. Erickson, Pharm.D.
1524 -- Bupropion May Support Psychosocial Treatment of Nicotine-Dependent Adolescents: Preliminary Results
Helmut Niederhofer, M.D., Ph.D., and Markus Huber, M.D.
1529 -- Frequency of New-Onset Diabetes Mellitus and Use of Antipsychotic Drugs Among Central Texas Veterans
Jamie C. Barner, Ph.D., Jason Worchel, M.D., and Min Yang, M.S.
1539 -- Magnitude and Duration of Elevated Gastric pH in Patients Infected with Human Immunodeficiency Virus After Administration of Chewable, Dispersible, Buffered Didanosine Tablets
Daryl D. DePestel, Pharm.D., Powel H. Kazanjian, M.D., Sandro K. Cinti, M.D., Carol A. Kauffman, M.D., and Peggy L. Carver, Pharm.D.
1546 -- Follow-up of Adverse Drug Reactions from Peginterferon alfa-2b-Ribavirin Therapy
Haleh Bagheri, Pharm.D., Ph.D., Atoussa Fouladi, Pharm.D., Karl Barange, M.D., Maryse Lapeyre-Mestre, M.D., Jean-Louis Payen, M.D., Jean Louis Montastruc, M.D., Ph.D., and Jean-Pierre Vinel, M.D., Ph.D.
REVIEW OF THERAPEUTICS
1554 -- Drug-Eluting Stents: A Mechanical and Pharmacologic Approach to Coronary Artery Disease
Paul P. Dobesh, Pharm.D., Zachary A. Stacy, Pharm.D., Alexander J. Ansara, Pharm.D., and Jason M. Enders, Pharm.D.
MINIREVIEW
1578 -- Intravenous Ethanol for the Treatment of Alcohol Withdrawal Syndrome in Critically Ill Patients
Brian Hodges, Pharm.D., and Joseph E. Mazur, Pharm.D.
PRACTICE INSIGHTS
1586 -- Key References in Infectious Diseases Pharmacotherapy
Richard H. Drew, Pharm.D., M.S., on Behalf of the American College of Clinical Pharmacy Infectious Diseases Practice and Research Network Bibliography Group
1594 -- High-Impact Articles Related to the Pharmacotherapeutic Management of Systolic Heart Failure
Tien M. H. Ng, Pharm.D., Orly Carter, Pharm.D., Gregory S. Guillory, Pharm.D., Patricia A. Howard, Pharm.D., FCCP, Craig R. Lee, Pharm.D., Jo E. Rodgers, Pharm.D., Patricia A. Uber, Pharm.D., Barbara S. Wiggins, Pharm.D., Mark A. Munger, Pharm.D., FCCP, and J. Herbert Patterson, Pharm.D., FCCP
CASE REPORTS
1634 -- Interaction Between Nesiritide and a Heparin-Coated Pulmonary Artery Line During an Infusion for Decompensated Heart Failure
Steven A. Baroletti, Pharm.D., and Heather D. Wahlstrom, Pharm.D.
1638 -- Early Evaluation of Hematuria in a Patient Receiving Anticoagulant Therapy and Detection of Malignancy
Toni L. Ripley, Pharm.D., Dawn E. Havrda, Pharm.D., Steve Blevins, M.D., and Daniel Culkin, M.D.
1641 -- Empiric Treatment of Multidrug-Resistant Burkholderia cepacia Lung Exacerbation in a Patient with Cystic Fibrosis: Application of Pharmacodynamic Concepts to Meropenem Therapy
Joseph L. Kuti, Pharm.D., Kerry M. Moss, M.D., David P. Nicolau, Pharm.D., FCCP, and R. Frederic Knauft, M.D.
1646 -- Benefit of Ribose in a Patient with Fibromyalgia
Benjamin Gebhart, Pharm.D., and James A. Jorgenson, M.S., FASHP
ALTERNATIVE VIEWPOINTS
1649 -- Tegaserod-Induced Myocardial Infarction: Case Report and Hypothesis -- An Alternative Viewpoint
Hans-Juergen Pfannkuche, Ph.D., and Eslie Dennis, M.D.
1652 -- The Use of Antibiotics as Secondary Prevention for Cardiac Events
Lyn-Li Lim, M.B. B.S., FRACP, Despina Kotsanas, B.Sc., Lars Ostergaard, M.D., Ph.D., D.M.Sc., and Ian Woolley, M.B. B.S., FRACP